Drug intelligence / Profile preview

Brovit

Development stage: Unknown
Lead developer: Kaizen Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Brovit is a multi-ingredient nutritional supplement and finished generic formulation manufactured by Kaizen Pharmaceuticals. It is formulated as a capsule containing a combination of the antioxidant lycopene, essential vitamins (A, C, and E), and minerals (Zinc and Selenium). The product is intended for general health prophylaxis and the improvement of immune system function. It is typically distributed in ALU-ALU packaging (10x10 capsules) and serves as a nutraceutical intervention to support cellular health and combat oxidative stress.

Brand names: Brovit

Targets

RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Brovit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brovit.

Explore the full profile